CNS Therapeutics - Ownership and Business Overview

Life ScienceCompany

CNS Therapeutics Ownership

Who owns CNS Therapeutics?

CNS Therapeutics is owned by Mallinckrodt. It was acquired on September 24, 2012.

CNS Therapeutics Business Overview

Where is CNS Therapeutics headquartered?

CNS Therapeutics is headquartered in St. Paul, Minnesota.

What sector is CNS Therapeutics in?

CNS Therapeutics is a life science company.

When was CNS Therapeutics founded?

CNS Therapeutics was founded in 2007.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 124 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 106 by strategics.

CNS Therapeutics, Inc.

332 Minnesota Street,
St. Paul, Minnesota 55101
United States,
(651)207-6959

CNS Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for site-specific administration to the central nervous system to treat neurological disorders and intractable chronic pain.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.